Manasi Das

1.8k total citations
22 papers, 1.4k citations indexed

About

Manasi Das is a scholar working on Molecular Biology, Biomaterials and Physiology. According to data from OpenAlex, Manasi Das has authored 22 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Biomaterials and 5 papers in Physiology. Recurrent topics in Manasi Das's work include RNA Interference and Gene Delivery (5 papers), Nanoparticle-Based Drug Delivery (5 papers) and Curcumin's Biomedical Applications (4 papers). Manasi Das is often cited by papers focused on RNA Interference and Gene Delivery (5 papers), Nanoparticle-Based Drug Delivery (5 papers) and Curcumin's Biomedical Applications (4 papers). Manasi Das collaborates with scholars based in United States, India and South Korea. Manasi Das's co-authors include Sanjeeb Kumar Sahoo, Chandana Mohanty, Nicholas J. G. Webster, Consuelo Sauceda, Wei Duan, Paromita Kundu, Jagat R. Kanwar, Lesley G. Ellies, Ranjita Misra and Deepak Kumar and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Blood.

In The Last Decade

Manasi Das

22 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manasi Das United States 16 584 451 306 287 156 22 1.4k
Vahid Shafiei‐Irannejad Iran 25 648 1.1× 525 1.2× 111 0.4× 362 1.3× 84 0.5× 54 1.7k
Yu Zheng China 23 681 1.2× 595 1.3× 109 0.4× 367 1.3× 62 0.4× 78 1.8k
Guangxi Zhai China 18 497 0.9× 473 1.0× 135 0.4× 376 1.3× 68 0.4× 28 1.5k
Xingmei Duan China 26 847 1.5× 341 0.8× 56 0.2× 280 1.0× 62 0.4× 56 1.7k
Liangke Zhang China 25 502 0.9× 563 1.2× 148 0.5× 601 2.1× 32 0.2× 59 1.8k
Huae Xu China 27 918 1.6× 558 1.2× 207 0.7× 623 2.2× 107 0.7× 70 2.1k
Chang Su China 22 536 0.9× 424 0.9× 81 0.3× 225 0.8× 25 0.2× 43 1.2k
Weiping Zheng China 24 886 1.5× 202 0.4× 78 0.3× 119 0.4× 123 0.8× 66 2.0k
Doaa A. Abdelmonsif Egypt 19 403 0.7× 247 0.5× 70 0.2× 137 0.5× 154 1.0× 43 1.3k
Ziming Zhao China 21 374 0.6× 333 0.7× 91 0.3× 218 0.8× 47 0.3× 56 1.1k

Countries citing papers authored by Manasi Das

Since Specialization
Citations

This map shows the geographic impact of Manasi Das's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manasi Das with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manasi Das more than expected).

Fields of papers citing papers by Manasi Das

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manasi Das. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manasi Das. The network helps show where Manasi Das may publish in the future.

Co-authorship network of co-authors of Manasi Das

This figure shows the co-authorship network connecting the top 25 collaborators of Manasi Das. A scholar is included among the top collaborators of Manasi Das based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manasi Das. Manasi Das is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Das, Manasi, Deepak Kumar, Consuelo Sauceda, et al.. (2024). Time-Restricted Feeding Attenuates Metabolic Dysfunction-Associated Steatohepatitis and Hepatocellular Carcinoma in Obese Male Mice. Cancers. 16(8). 1513–1513. 7 indexed citations
2.
Gao, Hong, Karina Cunha e Rocha, Zhongmou Jin, et al.. (2024). Restoring SRSF3 in Kupffer cells attenuates obesity-related insulin resistance. Hepatology. 80(2). 363–375. 4 indexed citations
3.
Sauceda, Consuelo, et al.. (2023). Stimulating Antitumoral Immunity by Percutaneous Cryoablation and Combination Immunoadjuvant Therapy in a Murine Model of Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology. 34(9). 1516–1527.e6. 6 indexed citations
4.
Herdman, D. Scott, Sung Min Lee, Ailin Tao, et al.. (2023). Loss of cAMP Signaling in CD11c Immune Cells Protects Against Diet-Induced Obesity. Diabetes. 72(9). 1235–1250. 5 indexed citations
5.
Das, Manasi & Nicholas J. G. Webster. (2022). Obesity, cancer risk, and time-restricted eating. Cancer and Metastasis Reviews. 41(3). 697–717. 21 indexed citations
6.
Das, Manasi, Lesley G. Ellies, Deepak Kumar, et al.. (2021). Time-restricted feeding normalizes hyperinsulinemia to inhibit breast cancer in obese postmenopausal mouse models. Nature Communications. 12(1). 565–565. 65 indexed citations
7.
Misra, Ranjita, et al.. (2021). EGFR targeted Mn-doped ZnO fluorescent nanocrystals for cancer theranostic application. Materials Today Communications. 26. 102170–102170. 7 indexed citations
8.
Das, Manasi, Consuelo Sauceda, & Nicholas J. G. Webster. (2020). Mitochondrial Dysfunction in Obesity and Reproduction. Endocrinology. 162(1). 54 indexed citations
9.
Kumar, Deepak, Manasi Das, Consuelo Sauceda, et al.. (2019). Degradation of splicing factor SRSF3 contributes to progressive liver disease. Journal of Clinical Investigation. 129(10). 4477–4491. 80 indexed citations
10.
Das, Manasi, et al.. (2018). Evaluation of curcumin loaded chitosan/PEG blended PLGA nanoparticles for effective treatment of pancreatic cancer. Biomedicine & Pharmacotherapy. 102. 555–566. 118 indexed citations
11.
12.
Mohanty, Atish, Manasi Das, Hesham M. Amin, et al.. (2016). CCND1 Mutations Increase Protein Stability and Promote Ibrutinib Resistance in Mantle Cell Lymphoma. Blood. 128(22). 4094–4094. 8 indexed citations
13.
Misra, Ranjita, et al.. (2014). Reversal of multidrug resistance in vitro by co-delivery of MDR1 targeting siRNA and doxorubicin using a novel cationic poly(lactide-co-glycolide) nanoformulation. International Journal of Pharmaceutics. 475(1-2). 372–384. 51 indexed citations
14.
Das, Manasi, Wei Duan, & Sanjeeb Kumar Sahoo. (2014). Multifunctional nanoparticle–EpCAM aptamer bioconjugates: A paradigm for targeted drug delivery and imaging in cancer therapy. Nanomedicine Nanotechnology Biology and Medicine. 11(2). 379–389. 90 indexed citations
15.
Das, Manasi & Sanjeeb Kumar Sahoo. (2012). Folate Decorated Dual Drug Loaded Nanoparticle: Role of Curcumin in Enhancing Therapeutic Potential of Nutlin-3a by Reversing Multidrug Resistance. PLoS ONE. 7(3). e32920–e32920. 88 indexed citations
16.
Mohanty, Chandana, Manasi Das, & Sanjeeb Kumar Sahoo. (2012). Emerging role of nanocarriers to increase the solubility and bioavailability of curcumin. Expert Opinion on Drug Delivery. 9(11). 1347–1364. 154 indexed citations
17.
Mohanty, Chandana, Manasi Das, & Sanjeeb Kumar Sahoo. (2012). Sustained Wound Healing Activity of Curcumin Loaded Oleic Acid Based Polymeric Bandage in a Rat Model. Molecular Pharmaceutics. 9(10). 2801–2811. 175 indexed citations
18.
Das, Manasi, Fahima Dilnawaz, & Sanjeeb Kumar Sahoo. (2011). Targeted Nutlin-3A Loaded Nanoparticles Inhibiting P53–MDM2 Interaction: Novel Strategy for Breast Cancer Therapy. Nanomedicine. 6(3). 489–507. 26 indexed citations
19.
Mohanty, Chandana, Manasi Das, Jagat R. Kanwar, & Sanjeeb Kumar Sahoo. (2010). Receptor Mediated Tumor Targeting: An Emerging Approach for Cancer Therapy. Current Drug Delivery. 8(1). 45–58. 88 indexed citations
20.
Das, Manasi, Chandana Mohanty, & Sanjeeb Kumar Sahoo. (2009). Ligand-based targeted therapy for cancer tissue. Expert Opinion on Drug Delivery. 6(3). 285–304. 178 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vahid Shafiei‐Irannejad Breakdown of academic impact, for papers by Yu Zheng Breakdown of academic impact, for papers by Guangxi Zhai Breakdown of academic impact, for papers by Xingmei Duan Breakdown of academic impact, for papers by Liangke Zhang Breakdown of academic impact, for papers by Huae Xu Breakdown of academic impact, for papers by Chang Su Breakdown of academic impact, for papers by Weiping Zheng Breakdown of academic impact, for papers by Doaa A. Abdelmonsif Breakdown of academic impact, for papers by Ziming Zhao
Rankless by CCL
2026